Top > News & Information > A new paper has been published.
A new paper has been published.
A new study performed in collaboration with Profs. Hiroshi Handa and Takumi Ito, Tokyo Medical University, has been
published in the open-access journal Communications Biology on November 11. This study shows that pomalidomide, a drug used for the treatment of multiple myeloma, causes a selective degradation of the disease-related protein PLZF, suggesting that the drug may also be applicable for the treatment of PLZF-associated types of leukemia.